CRBU
Price
$0.79
Change
+$0.03 (+3.95%)
Updated
May 8, 04:59 PM (EDT)
Capitalization
70.68M
5 days until earnings call
PMVP
Price
$0.89
Change
-$0.00 (-0.00%)
Updated
May 8, 04:57 PM (EDT)
Capitalization
46.23M
Earnings call today
Ad is loading...

CRBU vs PMVP

Header iconCRBU vs PMVP Comparison
Open Charts CRBU vs PMVPBanner chart's image
Caribou Biosciences
Price$0.79
Change+$0.03 (+3.95%)
Volume$15.72K
Capitalization70.68M
PMV Pharmaceuticals
Price$0.89
Change-$0.00 (-0.00%)
Volume$100
Capitalization46.23M
CRBU vs PMVP Comparison Chart
Loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRBU vs. PMVP commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Hold and PMVP is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (CRBU: $0.76 vs. PMVP: $0.89)
Brand notoriety: CRBU and PMVP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 43% vs. PMVP: 205%
Market capitalization -- CRBU: $70.68M vs. PMVP: $46.23M
CRBU [@Biotechnology] is valued at $70.68M. PMVP’s [@Biotechnology] market capitalization is $46.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whilePMVP’s FA Score has 1 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • PMVP’s FA Score: 1 green, 4 red.
According to our system of comparison, both CRBU and PMVP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 5 TA indicator(s) are bullish while PMVP’s TA Score has 4 bullish TA indicator(s).

  • CRBU’s TA Score: 5 bullish, 3 bearish.
  • PMVP’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CRBU is a better buy in the short-term than PMVP.

Price Growth

CRBU (@Biotechnology) experienced а -10.68% price change this week, while PMVP (@Biotechnology) price change was -10.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.88%. For the same industry, the average monthly price growth was +15.29%, and the average quarterly price growth was -13.75%.

Reported Earning Dates

CRBU is expected to report earnings on Aug 12, 2025.

PMVP is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-3.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRBU($70.7M) has a higher market cap than PMVP($46.2M). PMVP YTD gains are higher at: -41.073 vs. CRBU (-52.201). PMVP has higher annual earnings (EBITDA): -84.3M vs. CRBU (-162.69M). CRBU has more cash in the bank: 210M vs. PMVP (169M). PMVP has less debt than CRBU: PMVP (1.19M) vs CRBU (26.5M). CRBU has higher revenues than PMVP: CRBU (9.99M) vs PMVP (0).
CRBUPMVPCRBU / PMVP
Capitalization70.7M46.2M153%
EBITDA-162.69M-84.3M193%
Gain YTD-52.201-41.073127%
P/E RatioN/AN/A-
Revenue9.99M0-
Total Cash210M169M124%
Total Debt26.5M1.19M2,227%
TECHNICAL ANALYSIS
Technical Analysis
CRBUPMVP
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 15 days ago
77%
Bullish Trend 18 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HALO70.1410.76
+18.12%
Halozyme Therapeutics
GRND24.030.67
+2.87%
Grindr
INTU641.1414.59
+2.33%
Intuit
PYXS1.07N/A
N/A
Pyxis Oncology
ZVRA7.51-0.49
-6.12%
Zevra Therapeutics

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with CCCC. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
+0.76%
CCCC - CRBU
55%
Loosely correlated
+6.38%
CRSP - CRBU
53%
Loosely correlated
+3.29%
FATE - CRBU
51%
Loosely correlated
+4.41%
ALLO - CRBU
51%
Loosely correlated
-6.25%
AXON - CRBU
50%
Loosely correlated
+0.02%
More

PMVP and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMVP has been loosely correlated with RCKT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PMVP jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMVP
1D Price
Change %
PMVP100%
+2.28%
RCKT - PMVP
49%
Loosely correlated
+6.18%
XNCR - PMVP
42%
Loosely correlated
-5.61%
CLLS - PMVP
39%
Loosely correlated
-3.48%
RGNX - PMVP
39%
Loosely correlated
-8.59%
COGT - PMVP
38%
Loosely correlated
+0.43%
More